News

August 22, 2016August 22, 2016

Psoriasis Can Take Heavy Toll on Quality of Life, Study Says

News

Psoriasis significantly affects a person’s quality of life, with a number of patients — especially women, and those over age 55 — experiencing anxiety and symptoms of depression because of their disease, researchers ... Read more

August 19, 2016August 19, 2016

Severe Psoriasis Linked to High Risk of an Aortic Aneurysm, Especially in Younger Men

News

People with psoriasis, a condition linked to systematic and vascular inflammation as much as inflamed skin, are at risk of an aortic aneurysm — and the risk rises with the severity ... Read more

August 18, 2016

Review Highlights Links Between Psoriasis and Diet, Nutrition, Obesity

News

Growing evidence suggests that nutrition plays a major role in the development of psoriasis, with the likelihood that body weight and diet will exacerbate or trigger the disease. In a recent ... Read more

August 17, 2016August 17, 2016

Survey of Psoriasis Patients Highlights Disease’s Emotional Toll, Treatment Challenges

News

A new survey by Health Union, titled “Psoriasis in America 2016,” has revealed that although psoriasis patients agree that a variety of treatment plans are available, they find it difficult to find one that ... Read more

August 15, 2016August 15, 2016

Biologics May Be Effective Option for Children with Generalized Pustular Psoriasis

News

Biologics may be a promising treatment for pediatric patients with generalized pustular psoriasis (GPP) who are not responding to traditional therapies, but clinical trials better establishing their safety and efficacy ... Read more

August 11, 2016August 11, 2016

Coherus Reports Positive Initial Data in Ongoing Study of Humira Biosimilar to Treat Plaque Psoriasis

News

Coherus BioSciences recently reported that its ongoing Phase 3 pharmacokinetic and bioequivalence study comparing biosimilar CHS-1420, a candidate treatment for plaque psoriasis, to Humira (adalimumab) successfully met its 12-week endpoints. Specifically, the study demonstrated similarity ... Read more

August 10, 2016August 10, 2016

Potential Oral Treatment for Psoriasis Shows Efficacy in Phase 2/3 Study

News

Can-Fite BioPharma has announced the completion of its Phase 2/3 clinical trial evaluating Piclidenoson (CF101) as an oral treatment for moderate to severe psoriasis. The results show that Piclidenoson is both ... Read more

August 9, 2016August 9, 2016

Psoriasis Patients at High Risk of Chronic Pancreatitis, Study Finds

News

People with psoriasis, especially those with severe psoriasis, are at high risk of chronic pancreatitis (CP), researchers reported in the study, “The Risk of Chronic Pancreatitis in Patients with Psoriasis: A ... Read more

August 8, 2016August 8, 2016

Psoriasis Linked to Social Anxiety and Depression in Study

News

Psoriasis is linked to depression, poor sleep quality, and anxiety interacting with and being around others, researchers from University Hospital Policlinico-Vittorio Emanuele in Italy reported. The findings were recently published in the International Journal ... Read more

August 5, 2016August 5, 2016

Results of Pivotal Studies Show Taltz Treatment Helped Plaque Psoriasis Patients Be More Productive

News

Results from three, Phase 3 clinical trials showed that patients with moderate-to-severe psoriasis who were treated with Taltz (ixekizumab) reported significant improvements in work productivity over those treated with placebo. The randomized, double-blind, studies were led ... Read more